OrthoPediatrics (KIDS) reported Monday preliminary Q4 net revenue of $52.7 million, up from $37.6 million a year earlier.
Analysts polled by FactSet expect $50.7 million.
The company expects 2025 revenue of $235 million to $242 million, up 15% to 18% from the preliminary figure of $204.7 million.
Analysts surveyed by FactSet project $239.9 million.
OrthoPediatrics plans to release Q4 and 2024 results in early March.
Price: 25.44, Change: +0.44, Percent Change: +1.76
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。